Extended reality for procedural planning and guidance in structural heart disease - a review of the state-of-the-art.

Catheter planning Extended reality Procedure guidance Structural heart disease Surgical planning Virtual reality

Journal

The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 23 09 2022
accepted: 22 02 2023
medline: 12 6 2023
pubmed: 27 4 2023
entrez: 27 4 2023
Statut: ppublish

Résumé

Extended reality (XR), which encompasses virtual, augmented and mixed reality, is an emerging medical imaging display platform which enables intuitive and immersive interaction in a three-dimensional space. This technology holds the potential to enhance understanding of complex spatial relationships when planning and guiding cardiac procedures in congenital and structural heart disease moving beyond conventional 2D and 3D image displays. A systematic review of the literature demonstrates a rapid increase in publications describing adoption of this technology. At least 33 XR systems have been described, with many demonstrating proof of concept, but with no specific mention of regulatory approval including some prospective studies. Validation remains limited, and true clinical benefit difficult to measure. This review describes and critically appraises the range of XR technologies and its applications for procedural planning and guidance in structural heart disease while discussing the challenges that need to be overcome in future studies to achieve safe and effective clinical adoption.

Identifiants

pubmed: 37103667
doi: 10.1007/s10554-023-02823-z
pii: 10.1007/s10554-023-02823-z
pmc: PMC10250452
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1405-1419

Subventions

Organisme : British Heart Foundation
ID : TA/F/20/210021
Pays : United Kingdom
Organisme : British Heart Foundation
ID : TA/F/20/210021
Pays : United Kingdom
Organisme : British Heart Foundation
ID : TA/F/20/210021
Pays : United Kingdom
Organisme : British Heart Foundation
ID : TA/F/20/210021
Pays : United Kingdom
Organisme : British Heart Foundation
ID : TA/F/20/210021
Pays : United Kingdom
Organisme : British Heart Foundation
ID : TA/F/20/210021
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

JTCVS Tech. 2021 Jun;7:269-277
pubmed: 34100000
J Cardiothorac Vasc Anesth. 2019 Mar;33(3):732-741
pubmed: 30340952
Int J Environ Res Public Health. 2022 Feb 02;19(3):
pubmed: 35162742
Front Cardiovasc Med. 2021 Feb 09;8:633611
pubmed: 33634174
BMC Oral Health. 2019 Nov 8;19(1):238
pubmed: 31703708
Innovations (Phila). 2016 Jan-Feb;11(1):31-9; discussion 39
pubmed: 26938173
JACC Cardiovasc Imaging. 2019 May;12(5):921-924
pubmed: 30553676
Minerva Urol Nephrol. 2022 Oct;74(5):528-537
pubmed: 35383432
Heart Lung Circ. 2021 Feb;30(2):296-302
pubmed: 32863113
J Digit Imaging. 2022 Oct;35(5):1409-1418
pubmed: 35469355
Quant Imaging Med Surg. 2019 Jan;9(1):23-29
pubmed: 30788243
Kardiol Pol. 2017;75(10):1056
pubmed: 29057443
J Card Surg. 2021 Jul;36(7):2598-2602
pubmed: 33760302
JACC Case Rep. 2021 Oct 20;3(14):1579-1583
pubmed: 34729504
Eur Heart J. 2020 Feb 1;41(6):801
pubmed: 30977787
Healthc Technol Lett. 2019 Dec 2;6(6):220-225
pubmed: 32038861
Clin Radiol. 2021 Mar;76(3):237.e1-237.e7
pubmed: 33309030
Int J Comput Assist Radiol Surg. 2009 Mar;4(2):113-23
pubmed: 20033609
Congenit Heart Dis. 2018 May;13(3):357-361
pubmed: 29399969
Catheter Cardiovasc Interv. 2021 Mar;97(4):679-684
pubmed: 33444467
JACC Cardiovasc Interv. 2019 Jul 22;12(14):1389-1391
pubmed: 31103542
J Invasive Cardiol. 2020 Feb;32(2):76-81
pubmed: 31958070
World J Pediatr Congenit Heart Surg. 2020 Sep;11(5):627-629
pubmed: 32853059
Ann Thorac Surg. 2022 Jun;113(6):e457-e460
pubmed: 34481800
Int J Cardiovasc Imaging. 2015 Feb;31(2):323-8
pubmed: 25392054
Curr Rev Musculoskelet Med. 2021 Apr;14(2):192-203
pubmed: 33544367
Cardiovasc Ultrasound. 2007 Feb 16;5:8
pubmed: 17306019
Int J Cardiovasc Imaging. 2010 Dec;26(8):851-9
pubmed: 20535561
J Am Soc Echocardiogr. 2020 Nov;33(11):1306-1315
pubmed: 32981791
IEEE Trans Biomed Eng. 2013 Apr;60(4):1034-40
pubmed: 23047858
Circ Cardiovasc Imaging. 2019 Jul;12(7):e009297
pubmed: 31213088
PLoS Med. 2021 Mar 29;18(3):e1003583
pubmed: 33780438
J Imaging. 2021 Aug 19;7(8):
pubmed: 34460787
Med Ref Serv Q. 2017 Apr-Jun;36(2):171-178
pubmed: 28453428
Ann Thorac Surg. 2021 Jun;111(6):2078-2083
pubmed: 33689734
J Am Soc Echocardiogr. 2020 Jun;33(6):775-777
pubmed: 32199781
Ann Thorac Surg. 2021 Dec;112(6):2077-2083
pubmed: 34283956
Biomolecules. 2021 Jun 14;11(6):
pubmed: 34198642
Eur Heart J. 2021 Nov 1;42(41):4284
pubmed: 33246335
J Biomed Inform. 2020;112S:100077
pubmed: 34417006
Eur Heart J Digit Health. 2020 Nov 23;1(1):62-70
pubmed: 36713960
JMIR Cardio. 2020 Dec 8;4(1):e20633
pubmed: 33289675
Cardiovasc Ultrasound. 2005 Dec 23;3:37
pubmed: 16375768
Eur Heart J Cardiovasc Imaging. 2019 Aug 1;20(8):883-888
pubmed: 30534951
JACC Cardiovasc Interv. 2021 Aug 23;14(16):1854-1856
pubmed: 34412809
Eur Heart J Cardiovasc Imaging. 2016 Aug;17(8):845-9
pubmed: 27283456
Innovations (Phila). 2010 Nov;5(6):430-8
pubmed: 22437639
Kardiol Pol. 2018;76(1):212
pubmed: 29399769
J Am Soc Echocardiogr. 2020 May;33(5):641-644.e2
pubmed: 32139137
Eur Heart J Digit Health. 2021 Oct 28;2(4):667-675
pubmed: 36713107
J Thorac Cardiovasc Surg. 2008 Jun;135(6):1334-41
pubmed: 18544382
Eur Heart J Cardiovasc Imaging. 2019 Jul 1;20(7):839
pubmed: 31220228
Healthc Technol Lett. 2018 Sep 21;5(5):148-153
pubmed: 30800321

Auteurs

Natasha Stephenson (N)

School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK. Natasha.stephenson@kcl.ac.uk.
Department of Congenital Heart Disease, Evelina Children's Hospital, London, UK. Natasha.stephenson@kcl.ac.uk.
St Thomas' Hospital, 3rd Floor, Lambeth Wing, SE1 7EH, London, UK. Natasha.stephenson@kcl.ac.uk.

Kuberan Pushparajah (K)

School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Department of Congenital Heart Disease, Evelina Children's Hospital, London, UK.

Gavin Wheeler (G)

School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.

Shujie Deng (S)

School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.

Julia A Schnabel (JA)

School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Technical University of Munich, Munich, Germany.
Institute of Machine Learning in Biomedical Imaging, Helmholtz Center Munich, Munich, Germany.

John M Simpson (JM)

School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Department of Congenital Heart Disease, Evelina Children's Hospital, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH